Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Medicaid Work Mandate
  • Suicide Prevention
  • Community Health Workers
  • Rural Health Payout
  • Opioid Crisis

TRENDING TOPICS:

  • Medicaid Work Mandate
  • Suicide Prevention
  • Community Health Workers
  • Rural Health Payout
  • Opioid Crisis

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Wednesday, May 5 2021

Full Issue

Different Takes: FDA Rules Regarding Supplements Need Improvement; How Can We End Period Poverty?

Editorial writers examine these issues related to supplements, period poverty and nurse practitioners.

Chicago Tribune: FDA’s ‘Abundance Of Caution’ Should Extend To Supplements 

It’s a weird system when an effective vaccine was suspended during a deadly pandemic for a maybe-one-in-a-million chance of blood clots, but you can get free two-day shipping on an elixir of elk antler velvet. The U.S. Food and Drug Administration is known for being cautious — in the case of the Johnson & Johnson COVID-19 vaccine, the watchwords were “abundance of caution.” I can’t help but think: I sure wish these folks were more risk-averse when it comes to the supplements in my medicine cabinet. (Sarah Green Carmichael, 5/4)

The Philadelphia Inquirer: Period Products Should Be Free In Public Bathroom

Period poverty impacts a staggering 500 million people globally — a systemic problem that has gotten worse during COVID-19. Despite its prevalence, it continues to be largely ignored and limited access to menstrual products remains widespread, including in the United States. Changes to the U.S. federal tax code and important safety net programs could substantially reduce the number of Americans affected by this hardship. Period poverty — the inability to afford menstrual products due to financial constraints — exacerbates income inequality and amplifies the shame and stigma that continue to surround menstruation. (Misha Valencia, 5/4)

Modern Healthcare: The Evolving Scope Of Practice For Nurse Practitioners

Nearly half the states allow broad practice authority for nurse practitioners. Some of their limitations were also loosened in response to the COVID-19 pandemic. What restrictions, if any, do you believe should be part of licensing nurse practitioners? (Sophia Thomas and Dr. Susan Bailey, 5/4)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, April 29
  • Tuesday, April 28
  • Monday, April 27
  • Friday, April 24
  • Thursday, April 23
  • Wednesday, April 22
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF